Safety and immunogenicity of anti-SARS CoV-2 conjugate vaccine SOBERANA 02 in a two-dose or three-dose heterologous scheme in adults: Phase IIb Clinical Trial.
暂无分享，去创建一个
Castillo | A. Biglari | D. Doroud | D. García-Rivera | V. Verez-Bencomo | Tammy | Y. Valdés-Balbín | L. Rodríguez-Noda | Daniel García-Rivera | D. Santana-Mederos | Romero | Carmen | Y. García-Vega | M. E. Toledo-Romaní | Mayra García-Carmenate | Hernández | T. Hernández-García | J. Enriquez-Puertas | A. Palenzuela-Diaz | Y. Climent-Ruiz | Suzel Pérez-Rodríguez | Meybis Rodriguez-González | Ivette Orosa-Vázquez | M. T. Pérez-Guevara | Ivis Mendoza-Hernández | Yaima Muñoz | Yanet Gómez-Maceo | Bertha Leysi Santos-Vega | Guang-Wu-Chen | Sánchez-Ramírez | Yury Valdés-Balbín | Gerardo Baró-Román | Belinda | Beatriz | Leslyhana | Verdecia-Sánchez | Valenzuela-Silva | Paredes-Moreno | Raúl | González-Mugica | -. MariannizDíaz | -. EnriqueNoa | -. SonsireFernandez | Boggiano-Ayo | Darielys Santana-Mederos | M. García-Carmenate | Tays Hernández-García | Ariel Palenzuela-Diaz | Yanet Climent-Ruiz